Delivery Order SPE2DB24D1034-SPE2DB25FWAR1

Award Date 2/21/25
Potential Completion Date 2/24/25
Potential Value $3.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VYVANSE 40 MG CAPSULE 100S. The contract is a firm fixed-price delivery order with a ceiling value of $1,293.00 and an ultimate completion date of August 13, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of VYVANSE 20 MG CAPSULE 100S. The award has a ceiling value of $1,673.36 and a completion date of September 10, 2024. The contract is a Firm Fixed Price type. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies, valued up to $999,999,999 and $750,000, respectively,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of VYVANSE 30 MG CAPSULE 100S. The contract has a firm fixed price ceiling value of $1,617.70 and a period of performance ending on August 29, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,833.26, is for the supply of VYVANSE 40 MG CAPSULE 100S, a pharmaceutical product. The contract has a final completion date of December 3, 2024 and is a firm fixed-price, delivery order contract. The award was not set aside for a specific business type. AmerisourceBergen also holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,551.13, is for the supply of 4563828087 - VYVANSE 40 MG CAPSULE 100S, a specialty medication. The delivery order has a firm fixed price pricing type and an ultimate completion date of March 4, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VYVANSE 70 MG CAPSULE 100S, a prescription medication, to support federal healthcare programs. The contract has a ceiling value of $1,078.98 and runs through February 19, 2025. The contract is a Firm Fixed Price delivery order and does not have a set-aside designation, indicating open...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,675.40, is a firm fixed-price delivery order for 4566841648 - VYVANSE 40 MG CAPSULE 100S. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of VYVANSE 40 MG CAPSULE 100S, a prescription medication. The contract has a total ceiling value of $1,011.82 and a period of performance through August 13, 2024. Amerisourcebergen has been awarded this contract as a firm fixed price delivery order, with no set-aside designation. This...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,885.75, is for the supply of VYVANSE 40 MG CAPSULE 100S, a medication. The contract has an ultimate completion date of January 29, 2025 and is a firm fixed-price contract. AmerisourceBergen Drug Corp is a for-profit organization and a registered vendor in the System for Award Management...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,819.10 firm fixed-price contract is for the delivery of VYVANSE 30 MG CAPSULE 100S, a specialty pharmaceutical product. The contract has a completion date of January 23, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
  • SPE2DB24D1034
    Indefinite Delivery Contract
  • SPE2DB24D1034-SPE2DB25FWAR1
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VYVANSE 40 MG CAPSULE 100S. The contract has a ceiling value of $3,433.26 and runs through February 24, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/23/25, 10:14 AM